Considering other changes in CSF apolipoproteins, as in our previous work [5], we detected increased levels of ApoE (Fig. 1E, p = 0.0010) and ApoJ (Fig. 1F, p = 0.0423) in CSF from PD patients compared to controls. This evidence concerns the gene APOE and Parkinson disease.